Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -144,735 | -111,736 | -77,350 | -35,907 | -301,743 |
| Depreciation Amortization | -5,001 | -4,052 | -2,929 | -1,547 | -8,952 |
| Accounts receivable | 359 | 315 | 345 | 147 | 39,602 |
| Accounts payable and accrued liabilities | 580 | 305 | 338 | 1,871 | -19,102 |
| Other Working Capital | -1,083 | -1,175 | 760 | -9,203 | -45,831 |
| Other Operating Activity | 26,537 | 20,903 | 13,764 | 4,815 | 168,379 |
| Operating Cash Flow | $-123,343 | $-95,440 | $-65,072 | $-39,824 | $-167,647 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,177 | -15,377 | -20,637 | -43,648 | 112,014 |
| PPE Investments | -138 | -52 | -28 | -11 | -36,360 |
| Investing Cash Flow | $14,039 | $-15,429 | $-20,665 | $-43,659 | $75,654 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,077 | 3,701 | 1,042 | 970 | 2,132 |
| Other Financing Activity | 252,952 | 253,536 | 64,589 | 64,692 | -1,784 |
| Financing Cash Flow | $257,029 | $257,237 | $65,631 | $65,662 | $348 |
| Exchange Rate Effect | 1,074 | 956 | 805 | 197 | -438 |
| Beginning Cash Position | 78,837 | 78,837 | 78,837 | 78,837 | 170,920 |
| End Cash Position | 227,636 | 226,161 | 59,536 | 61,213 | 78,837 |
| Net Cash Flow | $148,799 | $147,324 | $-19,301 | $-17,624 | $-92,083 |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,343 | -95,440 | -65,072 | -39,824 | -167,647 |
| Capital Expenditure | -138 | -52 | -28 | -11 | -36,360 |
| Free Cash Flow | -123,481 | -95,492 | -65,100 | -39,835 | -204,007 |